Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti–Helicobacter pylori therapy☆
To access this article, please choose from the options below
☆ Supported in part by Associazione Italiana per la Ricerca sul Cancro (AIRC-Milan) and 1473 Fondazione del Monte di Bologna e Ravenna.
PII: S0016-5085(02)15894-X
doi:10.1053/gast.2003.50043
© 2003 The American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.

